Butterfly Network Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
$BFLY
Medical Electronics
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 18, 2026
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
| (Address of principal executive offices) | (Zip Code) | ||||
Registrant’s telephone number, including area code: (781 ) 557-4800
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders
On June 18, 2026, Butterfly Network, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders in order for stockholders to consider and vote on the three proposals set forth below, each of which is described in detail in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 27, 2026 (the “proxy statement”). The holders of 163,228,826 shares of Class A common stock were present or represented by proxy at the meeting. The holders of 26,426,937 shares of Class B common stock were present or represented by proxy at the meeting. Holders of the Class A common stock and Class B common stock voted together as a single class. Each share of Class A common stock entitles holders to one vote per proposal, while each share of Class B common stock entitles holders to 20 votes per proposal. The results for the votes for each proposal are set forth below.
The following actions were taken at such meeting:
1.Each of Joseph DeVivo; Jonathan M. Rothberg, Ph.D.; Larry Robbins; Caroll H. Neubauer; Elazer Edelman, M.D., Ph.D.; S. Louise Phanstiel; and Erica Schwartz, M.D., J.D., M.P.H. was elected as a director of the Company, to serve for a one-year term until the Company’s 2026 Annual Meeting of Stockholders and until their respective successor has been elected and qualified. The votes cast in the election of the directors were as follows:
| Nominee | Votes For | Votes Against | Abstentions | Broker Non-Votes | ||||||||||
| Joseph DeVivo | 621,675,693 | 1,606,171 | 211,950 | 68,273,752 | ||||||||||
| Jonathan M. Rothberg, Ph.D. | 622,369,243 | 898,308 | 226,263 | 68,273,752 | ||||||||||
| Larry Robbins | 622,081,118 | 1,191,480 | 221,216 | 68,273,752 | ||||||||||
| Caroll H. Neubauer | 622,482,090 | 785,388 | 226,336 | 68,273,752 | ||||||||||
| Elazer Edelman, M.D., Ph.D. | 622,169,037 | 1,097,459 | 227,318 | 68,273,752 | ||||||||||
| S. Louise Phanstiel | 621,997,159 | 1,168,660 | 327,995 | 68,273,752 | ||||||||||
| Erica Schwartz, M.D., J.D., M.P.H. | 621,848,491 | 1,430,748 | 214,575 | 68,273,752 | ||||||||||
2.The Company’s stockholders approved the proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes cast on this proposal were as follows:
| Votes For | Votes Against | Abstentions | ||||||
| 690,013,905 | 1,037,128 | 716,533 | ||||||
3.The Company’s stockholders approved by a non-binding advisory vote the compensation of the Company’s named executive officers, as disclosed in the proxy statement. The votes cast on this proposal were as follows:
| Votes For | Votes Against | Abstentions | Broker Non-Votes | ||||||||
| 614,118,861 | 8,857,243 | 517,710 | 68,273,752 | ||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| BUTTERFLY NETWORK, INC. | ||||||||
| By: | /s/ John Doherty | |||||||
| Name: | John Doherty | |||||||
| Title: | Executive Vice President, Chief Financial Officer | |||||||
| Date: June 22, 2026 | ||||||||